NCT00299767View on ClinicalTrials.gov

Phase I Study of Sequential Cord Blood Transplants

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2009

Conditions
LymphomaLeukemiaMultiple MyelomaMyelodysplastic Syndrome
Interventions
PROCEDURE

sequential cord blood transplantation

Infused on Day 0

Trial Locations (2)

02115

Dana Farber Cancer Institute, Boston

02116

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00299767 - Phase I Study of Sequential Cord Blood Transplants | Biotech Hunter | Biotech Hunter